Global Thyroid Eye Disease Treatment Market Report 2022-2028: A descriptive analysis and segmentation | Pfizer Inc.
Thyroid eye disease, also known as Graves Ophthalmopathy, is an autoimmune condition that develops in people with hyperactive thyroid gland.
United States Healthcare Pharmaceuticals Industry Premium Research Janssen Biotech Inc Pfizer Inc Tech Pharmacal Co Inc
Source: einnews.com